Stockreport

DiaMedica (DMAC) Up as Stroke Study Dosing Begins Post Relaunch [Yahoo! Finance]

DiaMedica Therapeutics Inc.  (DMAC) 
Last diamedica therapeutics inc. earnings: 11/13 04:12 pm Check Earnings Report
PDF the safety and efficacy of its lead product candidate, DM199, to treat acute ischemic stroke (AIS). The company's shares gained 9.7% on Apr 17, following the encouraging [Read more]